These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 9205016)
1. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. Chen JW; Lee WL; Hsu NW; Lin SJ; Ting CT; Wang SP; Chang MS Am J Cardiol; 1997 Jul; 80(1):32-8. PubMed ID: 9205016 [TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina. Raftery EB; Lahiri A; Hughes LO; Rose EL Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371 [TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris. Guermonprez JL; Blin P; Peterlongo F Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study. Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178 [TBL] [Abstract][Full Text] [Related]
5. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study. Hayata N; Araki H; Nakamura M Am Heart J; 1986 Dec; 112(6):1245-50. PubMed ID: 2947447 [TBL] [Abstract][Full Text] [Related]
6. Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris. Meany TB; Richardson P; Camm AJ; Coltart J; Griffith M; Maltz MB; Signy M Am J Cardiol; 1989 Jun; 63(21):66J-70J. PubMed ID: 2525329 [TBL] [Abstract][Full Text] [Related]
7. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina. Edwards RJ; Redwood SR; Lambiase PD; Marber MS Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027 [TBL] [Abstract][Full Text] [Related]
8. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Markham A; Plosker GL; Goa KL Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202 [TBL] [Abstract][Full Text] [Related]
9. Effect of nicorandil on exercise performance in patients with effort angina: a multicenter trial using a treadmill exercise test. Kato K; Asanoi H; Wakabayashi C; Hosoda S; Shiina A; Hosono K; Kurita A; Seki K; Ishida K; Kuroiwa A J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S98-103. PubMed ID: 2447432 [TBL] [Abstract][Full Text] [Related]
10. Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography. Yamazaki J; Ohsawa H; Uchi T; Iida M; Nakano H; Hosoi H; Morishita T; Yabe Y; Koyama N; Komatsu H Eur J Clin Pharmacol; 1993; 44(3):211-7. PubMed ID: 8491233 [TBL] [Abstract][Full Text] [Related]
11. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study. Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT. Yamazaki J; Iida M; Igarashi M; Hosoi H; Ishiguro S; Hou M; Morishita T; Nakano H; Yabe Y; Koyama N Int J Clin Pharmacol Ther; 1994 Apr; 32(4):183-91. PubMed ID: 8032578 [TBL] [Abstract][Full Text] [Related]
13. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. Camm AJ; Maltz MB Am J Cardiol; 1989 Jun; 63(21):61J-65J. PubMed ID: 2525328 [TBL] [Abstract][Full Text] [Related]
14. Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris. Ogino K; Osaki S; Noguchi N; Kitamura H; Omodani H; Kato M; Hisatome I; Matsumoto T; Kinugawa T; Miyakoda H Eur J Clin Pharmacol; 1995; 48(3-4):189-94. PubMed ID: 7589040 [TBL] [Abstract][Full Text] [Related]
15. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial. Acanfora D; Vitale DF; Rengo C; Iannuzzi GL; Furgi G; Picone C; Rossi M; Trojano L; Rengo F Cardiology; 1997; 88(4):353-60. PubMed ID: 9197430 [TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris. Di Somma S; Liguori V; Petitto M; Carotenuto A; Bokor D; de Divitiis O; de Divitiis M Cardiovasc Drugs Ther; 1993 Feb; 7(1):119-23. PubMed ID: 8485067 [TBL] [Abstract][Full Text] [Related]
17. Chronic effects of nicorandil on exercise tolerance in patients with stable effort angina pectoris. Hiasa Y; Hamai K; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y Tokushima J Exp Med; 1989 Dec; 36(3-4):65-70. PubMed ID: 2534651 [TBL] [Abstract][Full Text] [Related]
18. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris. Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina: effects on myocardial ischemia and heart rate variability. Acanfora D; Trojano L; Gheorghiade M; Picone C; Papa A; Furgi G; Giuliano F; Maestri R; Rengo F Am J Ther; 2002; 9(5):444-53. PubMed ID: 12237738 [TBL] [Abstract][Full Text] [Related]
20. Comparison of nicorandil and atenolol in stable angina pectoris. Hughes LO; Rose EL; Lahiri A; Raftery EB Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]